Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
LY6G6D Biologics Sequence Review Report 2026: Lymphocyte antigen 6 complex locus protein G6d Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of LY6G6D protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
LRP4 Biologics Sequence Review Report 2026: Low-density lipoprotein receptor-related protein 4 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of LRP4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
LRP5 Biologics Sequence Review Report 2026: Low-density lipoprotein receptor-related protein 5 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of LRP5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
INSR Biologics Sequence Review Report 2026: Insulin receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of INSR protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
RARRES1 Biologics Sequence Review Report 2026: Retinoic acid receptor responder protein 1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of RARRES1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
MBL2 Biologics Sequence Review Report 2026: Mannose-binding protein C Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of MBL2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GRM5 Biologics Sequence Review Report 2026: Metabotropic glutamate receptor 5 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GRM5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
FCN3 Biologics Sequence Review Report 2026: Ficolin-3 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of FCN3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
FOLR3 Biologics Sequence Review Report 2026: Folate receptor gamma Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of FOLR3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GDF5 Biologics Sequence Review Report 2026: Growth/differentiation factor 5 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GDF5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
VIPR2 Biologics Sequence Review Report 2026: Vasoactive intestinal polypeptide receptor 2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of VIPR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ACHE Biologics Sequence Review Report 2026: Acetylcholinesterase Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of ACHE protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
2
3
4
5
6
>>
1670
>